PARIS (EGMN) - Alterations in the expression of a well-known cancer gene called Myc may explain why some patients with non-small cell lung cancer are resistant to the effects of platinum-based chemotherapy.The first results of a gene expression profiling analysis of NSCLC samples, taken prospectively from patients during the BATTLE trial, were presented at the Worldwide Innovative Networking in Personalized Cancer Medicine Symposium."Myc is downregulated in treatment-refractory non-small cell lung...